免疫检查点阻塞延迟癌症的发展,并延长DNA聚合酶突变症综合征的生存期
Akshada Sawant1,2, Fuqian Shi1, Eduardo Cararo Lopes1
1Rutgers Cancer Institute, Rutgers University, New Brunswick, New Jersey.
Cancer research
|January 9, 2025
概括
在DNA聚合酶POLD1和POLE中的突变增加了癌症风险和瘤突变负担 (TMB). 在高风险小鼠中,早期免疫检查点阻塞 (ICB) 能够预防癌症,这表明在风险增加的个体中,癌症预防的潜力.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- DNA聚合酶POLD1和POLE的突变与癌症发病率的增加,瘤突变负担 (TMB) 的增加以及对免疫检查点阻塞 (ICB) 的反应的改善有关.
- 了解TMB如何影响瘤生物学和免疫治疗反应至关重要,因为并非所有高TMB的瘤都对ICB有反应.
研究的目的:
- 在小鼠模型中调查POLD1和POLE突变对癌症发展,TMB和对ICB的反应的影响.
- 探索ICB作为高风险个体癌症预防策略的潜力.
主要方法:
- 在Pold1和Pole的外核酶域中产生了生殖系和条件突变的小鼠.
- 分析了自发癌症的TMB和突变特征.
- 在已确定的瘤和预防性环境中评估瘤对ICB的反应.
主要成果:
- 工程小鼠发展自发性癌症 (淋巴瘤,肺,肠道,皮肤) 与增加的TMB和人类相关的突变特征.
- 在Pold1突变的尾部瘤中显示出高的TMB,但只有部分的ICB反应;在Kras/Trp53驱动的肺癌模型中,ICB没有改善存活率.
- 在突变小鼠中早期ICB治疗延迟了癌症发病和改善了存活率,选择了没有形积分的瘤.
结论:
- POLD1和POLE突变驱动高TMB的癌症,但由于免疫编辑等因素,已建立的瘤可能无法完全响应ICB.
- 在高风险人群中,ICB的早期管理显示为癌症预防策略的承诺,延迟癌症发病并改善存活率.
相关概念视频
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


